FDA Drug Application (085828) for SULFASALAZINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number085828
Product Number001
FormTABLET;ORAL
Dosage500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSULFASALAZINE
Active IngredientSULFASALAZINE

Active IngredientCount
List of drugs with Active Ingredient SULFASALAZINE4


Back to FDA Applications sponsored by WATSON LABS